Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07579702 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Study acronym: STRIVE 2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Completion pushed from Feb 1, 2027 to Mar 24, 2027 Study sites: 12 to 11 · Primary completion date: Feb 1, 2027 to Feb 22, 2027v4 Show 2 more changesShow less
    • Study sites: 12 to 11
    • Primary completion date: Feb 1, 2027 to Feb 22, 2027
  2. Minor Site details revised at 7 of 12 sitesv3
  3. Notable Recruitment opened Trial sites expanded: 0 → 12 locations · Start date changed from estimate of May 11, 2026 to May 13, 2026v2 Show 2 more changesShow less
    • Trial sites expanded: 0 → 12 locations
    • Start date changed from estimate of May 11, 2026 to May 13, 2026
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
4,286 trials monitored
See 187 trials at risk
2,100 trials monitored
See 102 trials at risk
853 trials monitored
See 38 trials at risk
This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
Trial Details
NCT Number NCT07579702
Lead Sponsor Insulet Corporation
Conditions Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov